The Australian Psychedelic Society (APS) is a grassroots, community-based not-for-profit. We strongly support the decriminalisation and informed use of psychedelics.
A large amount of our work involves advocacy and changing narratives around psychedelics. This includes raising awareness and educating our community (including leaders, physicians, and the general public) about the potential health benefits and risks when using these medicines, whether they are used recreationally, for mental health, physical health, spiritual development, consciousness exploration or other reasons.
We hope that in creating communities across Australia we can better advocate for the decriminalisation of psychedelics and reduce stigma associated with their use.
Featured Posts
Events
Can’t find what you’re looking for? Search below!
Volunteer with the Australian Psychedelic Society!
Clinical Trials
Keep up with the latest information about clinical trials and drug development through the research conducted by scientists around Australia.
Make a donation.
Your support allows the Australian Psychedelic Society to expand and reach more of our community, hold more events, and helps us and our community work toward our goals.
The Australian Psychedelic Society is a registered not-for-profit organisation, registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC).
We are currently working towards deductible gift recipient (DGR) status. This means that at the present time, donations to the APS are not tax deductible..
The APS Decriminalisation Panel Discussion
Learn about the APS’s stance on decriminalisation. In our Panel Discussion, we explore:
The current law's impacts on psychoactive substances.
The distinctions between decriminalisation and legalisation.
Potential benefits and risks of decriminalisation.
Our current focus on decriminalisation.
🎙 Our Panelists:
David Heilpern AM: Esteemed lawyer and former magistrate
Dr. Alex Wodak AM: Internationally recognised harm reduction and drug policy expert
Dr. Monica Barratt, drug policy researcher at RMIT University and Executive Director of Bluelight.org